Clinical trials: Photosensitive Epilepsy
Photosensitive Epilepsy
Effect of BGG492 on EEG in Patients With Photosensitive Epilepsy
This study will evaluate the efficacy of BGG492 in reducing the sensitivity to flashing lights of patients with photosensitive epilepsy, using EEG as a readout.
- Trial name
- NCT00784212
- Testing
- BGG492
- Where
- 4 sites in Germany
- Volunteers
- 13 people
- Sponsor
- Novartis Pharmaceuticals
Epilepsy
A Study to Investigate the Effect of ICA-105665 in Photosensitive Epilepsy Patients
Subjects with epilepsy with a documented photoparoxysmal response to intermittent photic stimulation (IPS) will participate. Four subjects will be enrolled at each dose level and will receive a single dose of placebo and a single…
- Trial name
- NCT00979004
- Testing
- ICA-105665
- Where
- 3 sites in United States
- Volunteers
- 13 people
- Sponsor
- Pfizer
Photosensitive Epilepsy
A Study to Evaluate the Pharmacodynamic Activity of E2730 in Adult Participants With Photosensitive Epilepsy
The primary purpose of the study is to assess the pharmacodynamic (PD) activity of E2730 as measured by suppression of epileptic photoparoxysmal response (PPR) in the participant's most sensitive eye condition in participants…
- Trial name
- NCT03603639
- Testing
- E2730
- Where
- 5 sites in United States
- Volunteers
- 6 people
- Sponsor
- Eisai Inc.
Photosensitive Epilepsy
A Study to Evaluate the Effect of ACT-709478 in Photosensitive Epilepsy Patients
The main study objective is to assess the effect of ACT-709478 in male and female subjects with photosensitive epilepsy following single dose administration
- Trial name
- NCT03239691
- Testing
- ACT-709478 for oral use
- Where
- 5 sites in France, Germany
- Volunteers
- 5 people
- Sponsor
- Idorsia Pharmaceuticals Ltd.
Epilepsy
Effect of Brivaracetam in Photosensitive Epileptic Subjects
to assess the effect of brivaracetam on the photoparoxysmal EEG response in photosensitive epileptic subjects
- Trial name
- NCT00401648
- Testing
- Brivaracetam
- Where
- 5 sites in France, Germany
- Volunteers
- 20 people
- Sponsor
- UCB Pharma
Photosensitive Epilepsy
A Study of the Effects of JNJ-26489112 on the Photic Induced Paroxysmal Electroencephalogram (EEG) Response in Patients With Photosensitive Epilepsy
The purpose of this study is to check the Effects of JNJ-26489112 on the Photic Induced Paroxysmal electroencephalogram (EEG) Response in Patients with Photosensitive Epilepsy.
- Trial name
- NCT00579384
- Testing
- JNJ-26489112
- Volunteers
- 12 people
- Sponsor
- Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Migraine
A Proof of Concept Alleviating the Symptoms of Photosensitive Migraine.
This proof of concept clinical study will investigate the efficacy of active lens with frame in alleviating the symptoms of migraine which are caused by photosensitivity.
- Trial name
- NCT04904328
- Testing
- Lumishade® Active Lens
- Volunteers
- 77 people
- Sponsor
- Mitsui Chemicals, Inc.
Photosensitive Epilepsy
A Study to Evaluate the Pharmacodynamic Activity of E2082 in Adult Participants With Photosensitive Epilepsy
The primary purpose of the study is to assess pharmacodynamic (PD) activity of E2082 as measured by suppression of epileptic photoparoxysmal response (PPR) in the participant's most sensitive eye condition in participants with…
- Trial name
- NCT03686033
- Testing
- E2082
- Where
- 5 sites in United States
- Volunteers
- 8 people
- Sponsor
- Eisai Inc.
Epilepsy
Efficacy of YKP3089 in Patients With Photosensitive Epilepsy
The aim of this study is to evaluate the ability of a single oral dose of YKP3089 to abolish or clearly reduce the IPS-induced photo-paroxysmal EEG response in photosensitive epilepsy patients, and to measure the onset and…
- Trial name
- NCT00616148
- Testing
- YKP3089
- Where
- 4 sites in United States
- Volunteers
- 11 people
- Sponsor
- SK Life Science, Inc.
Reflex Epilepsy, Photosensitive
PF-06372865 in Subjects With Photosensitive Epilepsy
PF-06372865 in subjects with photosensitive epilepsy
- Trial name
- NCT02564029
- Testing
- PF-06372865, Lorazepam
- Where
- 16 sites in United States
- Volunteers
- 7 people
- Sponsor
- Pfizer
Epilepsy
Safety, Tolerability, and Efficacy of RLS103 in a Clinical Model of Photosensitive Epilepsy
The purpose of this study is to evaluate RLS103 for safety and suppression of the epileptic photoparoxysmal response compared to placebo.
- Trial name
- NCT05678881
- Testing
- High dose RLS103, Low dose RLS103
- Volunteers
- 2 people
- Sponsor
- Receptor Life Sciences
Photosensitive Epilepsy, Epilepsy
A Double Blind, Randomized, Cross-over Study Examining the Suppression of the Photoparoxysmal EEG Response With NPT 2042
A double-blind, placebo-controlled, crossover trial to investigate the PPR of approximately 5 subjects with a known stable PPR on EEG, using 2 doses of NPT 2042 compared to placebo.
- Trial name
- NCT06525649
- Testing
- NPT 2042
- Where
- 2 sites in United States
- Volunteers
- 5 people
- Sponsor
- NeuroPro Therapeutics, Inc.